You are here:
Therapeutic
Areas
DECADES OF EXPERIENCE IN THESE THERAPEUTIC AREAS
When conducting studies in patients our flagship offerings are in HIV and TB as well as other Infectious Disease Vaccines and Therapeutics. Our execution partners have recently played a major role in recruiting large patient cohorts (>25,000 randomised) in several SARS-CoV-2 vaccine studies.
Infectious Diseases (Vaccines & Therapeutics)
- Human Immunodeficiency Virus (HIV)
- Tuberculosis (TB)
- Respiratory Syncytial Virus (RSV)
- Influenza Virus (Seasonal and Pandemic)
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- Varicella-Zoster Virus (VZV; Shingles)
- Hepatitis Virus (HBV & HCV)
- Meningococcal Bacteria (Meningococcal Disease)
- Pneumococcal Bacteria (IPD)
When conducting healthy volunteer studies, we offer First-in-Man and Bioequivalence studies as our flagship offerings. We offer a comprehensive bio-analytical laboratory service, packaged with the clinical procedures, or provided as standalone service.
Healthy Volunteers
- Bioequivalence and Bioavailability
- First-in-Man Safety (SAD & MAD)
- Drug-Drug Interaction
- Food Effect
- QT/QTc
In addition to the above, we can also deliver on select chronic disease therapeutic areas specialising in proof-of-concept (Phase 2a) studies in these therapeutic areas.
Autoimmune Disorders
- Atopic Dermatitis (AD or Eczema) and Psoriasis
- Crohn’s Disease and Ulcerative Colitis (IBD)
- Rheumatoid Arthritis (RA)
Chronic Metabolic Disorders (with/out CV complications)
- Diabetes (Type 1 and 2)
- Hypercholesterolemia and Hyperlipidaemia
- Cardiovascular Complications
- Atherosclerosis (Narrowing/Hardening of Arteries)
- Coronary Artery Stenosis (Heart Attack)
- Carotid Artery Stenosis (Stroke)
- Peripheral Artery Disease
Chronic Respiratory Disorders
- Asthma (Complicated and Uncomplicated)
- Chronic Obstructive Pulmonary Disease (COPD)
- Allergic Rhinitis (Hay Fever)
Musculoskeletal Disorders
- Osteoarthritis (OA)
